Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review
Nutrients · 28.12.2024 · 17 (1) · 85
DOI: 10.3390/nu17010085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 28.12.2024. Verfasst von Aurelio Seidita und 19 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Unit, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco, 180, 90146 Palermo, Italy. Hauptthemen laut MEDLINE: Celiac Disease, Fatty Liver, Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Palermo.
Abstract (Originalsprache)
Background/Objectives: An increasing number of studies have reported liver involvement in both children and adults with celiac disease (CD). This often manifests as isolated hypertransaminasemia or hepatic steatosis (HS). The aim of this study was to define the prevalence of hypertransaminasemia and HS in a pediatric population with CD before starting a gluten-free diet (GFD) and to analyze how the introduction of a GFD could modify this condition. We also conducted a state-of-the-art literature review of the association between hypertransaminasemia, metabolic dysfunction-associated steatotic liver disease (MASLD) and CD.
Methods
We retrospectively reviewed the clinical charts of pediatric CD patients diagnosed in three different pediatric units of Sicily, analyzing clinical, laboratory, ultrasound, and histology data before and 12 months after the introduction of a GFD.
Results
A total of 160 patients (65.0% females, median age 6.4 (0.8–13.2) years) were included; hypertransaminasemia and HS prevalences at diagnosis were 8.1% and 6.1%, respectively. Subjects with hypertransaminasemia were younger (p = 0.01) than those without and had higher frequencies of HS (p = 0.034) and anti-tissue transglutaminase (tTg) immunoglobulin (Ig)G positivity (p = 0.046). Subjects with HS were younger (p = 0.0001) and had a higher frequency of hypertransaminasemia (p = 0.029) compared to non-steatotic ones. After 12 months of a GFD, hypertransaminasemia and HS persisted in 53.8% and 50.0% of patients, respectively.
Conclusions
The prevalences of hypertransaminasemia and HS in Sicilian pediatric CD patients seem to be lower than those reported in other geographical areas. A GFD can reverse the trend of liver involvement, although periods of longer than 12 months may be necessary. However, a GFD has been associated with an increased prevalence of HS, and so regular follow-up involving a nutritionist should be recommended to guide physicians in patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine Unit, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco, 180, 90146 Palermo, Italy.
- Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Piazza delle Cliniche, 2, 90127 Palermo, Italy.
- Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy.
- Gastroenterology Unit, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco, 180, 90146 Palermo, Italy.
- Department of Pediatrics, University Hospital of Palermo, 90134 Palermo, Italy.
- Pediatric Gastroenterology Unit, "Di Cristina" Hospital, Palermo, 90134 Palermo, Italy.
ORCID-Profile: Aurelio Seidita, Federica Latteri, Alessandra Giuliano, Marta Chiavetta, Diana Di Liberto, Maurizio Soresi, Pasquale Mansueto, Antonio Carroccio
Förderung
- University of Palermo
Zitieren
APA
Seidita, A., Latteri, F., Pistone, M., Giuliano, A., Bertoncello, L., Cavallo, G., Chiavetta, M., Faraci, F., Nigro, A., Termini, A., Verona, L., Ammannato, A., Accomando, S., Cavataio, F., Lospalluti, M. L., Citrano, M., Di Liberto, D., Soresi, M., Mansueto, P., & Carroccio, A. (2024). Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review. Nutrients, 17(1), 85. https://doi.org/10.3390/nu17010085
Vancouver
Seidita A, Latteri F, Pistone M, Giuliano A, Bertoncello L, Cavallo G, et al. Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review. Nutrients. 2024;17(1):85. doi:10.3390/nu17010085
BibTeX
@article{Seidita2024,
author = {Seidita, Aurelio and Latteri, Federica and Pistone, Mirco and Giuliano, Alessandra and Bertoncello, Luca and Cavallo, Giorgia and Chiavetta, Marta and Faraci, Francesco and Nigro, Alessia and Termini, Alessandro and Verona, Laura and Ammannato, Agnese and Accomando, Salvatore and Cavataio, Francesca and Lospalluti, Maria Letizia and Citrano, Michele and Di Liberto, Diana and Soresi, Maurizio and Mansueto, Pasquale and Carroccio, Antonio},
title = {Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review},
journal = {Nutrients},
year = {2024},
volume = {17},
number = {1},
pages = {85},
doi = {10.3390/nu17010085}
}
EUVIMED